{"result": "(\"entity\"<|>ENCEFALOPATÍA<|>EVENT<|>Encefalopatía is a medical condition that affects the brain, often leading to various neurological symptoms and complications.)\n##\n(\"entity\"<|>PREDIALISIS<|>EVENT<|>Prediálisis refers to the stage before a patient begins dialysis treatment, often involving preparation and management of kidney function.)\n##\n(\"entity\"<|>ENF. PULMONAR<|>EVENT<|>Enfermedad Pulmonar (Pulmonary Disease) encompasses various conditions affecting the lungs, leading to breathing difficulties and other health issues.)\n##\n(\"entity\"<|>DISTRESS<|>EVENT<|>Distress is a state of emotional or physical suffering that can impact a patient's overall health and well-being.)\n##\n(\"entity\"<|>NE PRECOZ<|>EVENT<|>NE Precoz (Early Neuropathy) refers to the early onset of neuropathic symptoms, often related to underlying health conditions.)\n##\n(\"entity\"<|>PRE. CIR. TDS<|>EVENT<|>Pre. Cir. TDS (Preoperative Treatment for Total Dietary Support) involves preparing patients for surgery with specific dietary management.)\n##\n(\"entity\"<|>TRATAMIENTO QT-RT<|>EVENT<|>Tratamiento QT-RT (QT-RT Treatment) refers to a combined approach of chemotherapy and radiotherapy for cancer treatment.)\n##\n(\"entity\"<|>CRÍTICOS Y POST<|>EVENT<|>Críticos y Post (Critical and Postoperative Care) involves the management of patients in critical condition and their recovery after surgery.)\n##\n(\"entity\"<|>OBESIDAD<|>EVENT<|>Obesidad (Obesity) is a medical condition characterized by excessive body fat, which can lead to various health complications.)\n##\n(\"entity\"<|>DIABETES<|>EVENT<|>Diabetes is a chronic health condition that affects how the body processes blood sugar (glucose), leading to various health issues.)\n##\n(\"relationship\"<|>ENCEFALOPATÍA<|>PREDIALISIS<|>Encefalopatía can complicate the management of patients in pre-dialysis stages due to neurological symptoms affecting treatment compliance.<|>7)\n##\n(\"relationship\"<|>ENF. PULMONAR<|>DISTRESS<|>Pulmonary disease can lead to distress in patients due to difficulty in breathing and other respiratory issues.<|>8)\n##\n(\"relationship\"<|>NE PRECOZ<|>DIABETES<|>Early neuropathy is often a complication of diabetes, affecting nerve function and leading to various symptoms.<|>9)\n##\n(\"relationship\"<|>TRATAMIENTO QT-RT<|>CRÍTICOS Y POST<|>QT-RT treatment is often administered in critical care settings and requires careful postoperative management.<|>8)\n##\n(\"relationship\"<|>OBESIDAD<|>DIABETES<|>Obesity is a significant risk factor for developing diabetes, as excess body fat can lead to insulin resistance.<|>9)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: (Orientación)                 Encefalopatía        Prediálisis     Enf. Pulmonar       Distréss      NE precoz     Pre. Cir. TDS          Tratamiento QT-RT          Críticos y post        Obesidad           Diabetes           Diabetes            Diabetes\n                                                                   crónica/aguda      respiratorio                                                                         cirugía           mórbida\n                                                   Hipoproteica                Alto Lip                                                                                                                                          Hiperproteica      Hiperproteica\n Características                 Alto en AA         Hipercaló-              Hipercalórica           Hiperproteica   Hiperproteica     Hiperproteica Hipercalórica      Hiperproteica      Hiperproteica       Hiperproteica      Hipercalórica3     Alto AGMI, w3\n                                ramificados            rica                   Bajo HC                Arg RNA w3     Arg RNA w3                   Alto w3              Normocalórica        Hipocalórica        Alto AGMI        Alto AGMI, w           Bajo HC\n                                                                                                                                                                                                                                    Bajo HC\n Kcal/unidad                        411                472                       760                      505            334             750                 300           1000                211                 206                750                 499\n Kcal/ml                             1                   2                      1.51                       1             1.4             1,5                                  1                 0,8                0.9                 1,5                 1\n mOsm/l                             799                427                       384                      298            680             340                 435            315                492                 399                614                 378\n N (g)                              2.1                1.1                        5                       5.5            2,9               8                 3,2            8.8                 2,8                1.6                  6                  4\n Kcal no prot/g N                   176                400                       128                       71            55,4             69                 69             90,6               50,2                102                 98                 98\n Proteínas (g)                     12,9                7.1                        31                       28            18,1             50                 20              55                17,5               10.7                37,5                25\n AA (%)                             100                 ---                      ---                   22 (Arg)      23,2 (Arg)                    ---                    15 (Arg)              ---                ---                 ---                ---\n Oligopéptidos (%)                   ---                ---                      ---                       ---            ---                      ---                       ---                ---                ---                 ---                ---\n Energía                           9,7%                6%                       17%                      22%             22%                      27%                       20%                33%                21%                 20%                20%\n Hidratos C. (g)                   73,6                60.6                       53                       67            44,7             62                24,8            125                 25                25.5               64,75               37,3\n Monosacáridos (%)                 22,1                 ---                      ---                       ---            ---                      1,3                       ---                ---          19,6 (maltitol)    26,2 (maltitol)     20.3 (maltitol)\n Disacáridos (%)                   26,2                 10                        55                       ---           58,7            43,8               55,4             ---          33 (Fructosa)      22,8 (fructosa)    20,4 (fructosa)    26,3 (fructosa)\n Polisacáridos (%)                 51,6                 90                        45                      100            41,3            54,9               43,3            100                 67                 43                53,45               53,4\n Energía                           74,5%               51%                      28%                      53%             53%                      33%                       50%                48%                45%                 30%                31%\n Fibra (g)                           ---                ---                      ---                       ---           3,3               6                  3              15                3,75                 1                  8,5               10,5\n                                                                                                                   100% soluble    100% soluble        100% soluble    47% soluble        100% soluble            (FOS)          Mezcla+FOS          Mezcla+FOS\n Lípidos (g)                        7,2                22.7                       47                       14            9,2             33,5               13,4             33                 4,5                7.8                37,5               27,2\n MCT (%)                           76,7                 ---               20               25              22             29              34                23,8             ---                ---                ---                0,03                ---\n LCT (%)                           23,3                100                        80                       78             71              66                76,2            100                100                 100                 7,8                100\n Energía                           15,8%               43%              55%                              25\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}